Voyager Therapeutics (VYGR) Retained Earnings (2014 - 2026)
Voyager Therapeutics' (VYGR) quarterly Retained Earnings came in at -$263000.0 in Q1 2026, up 99.93% year-on-year from -$131548.4 in Q1 2025, and down 921.88% quarter-over-quarter from $32000.0 in Q4 2025.
Voyager Therapeutics (VYGR) Retained Earnings (2014 - 2026) Analysis & Trends
Voyager Therapeutics has disclosed Retained Earnings across 13 years of filings, most recently posting -$263000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$263000.0, up 99.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$263000.0 (up 99.93% YoY), and the FY2025 annual result was $32000.0, up 107.86% from the prior year.
- Retained Earnings came in at -$263000.0 for Q1 2026 at Voyager Therapeutics, down from $32000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $32000.0 in Q4 2025 to a low of -$418.5 million in Q3 2025.
- The 5-year median for Retained Earnings is -$282.7 million (2024), against an average of -$201.9 million.
- Across the five-year window, Retained Earnings sank 307439.68% in 2022 and jumped 107.86% in 2025, its largest moves.
- Voyager Therapeutics' Retained Earnings stood at -$219000.0 in 2022, then soared by 78.08% to -$48000.0 in 2023, then tumbled by 747.92% to -$407000.0 in 2024, then soared by 107.86% to $32000.0 in 2025, then tumbled by 921.88% to -$263000.0 in 2026.
- The last three Retained Earnings figures came in at -$263000.0 (Q1 2026), $32000.0 (Q4 2025), and -$418.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Voyager Therapeutics | 222.52 Mn | 81.04 Mn | - | -263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -263,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | -418.48 Mn |
| Jun 30, 2025 | -390.59 Mn |
| Mar 31, 2025 | -357.20 Mn |
| Dec 31, 2024 | -407,000.00 |
| Sep 30, 2024 | -291.70 Mn |
| Jun 30, 2024 | -282.70 Mn |
| Mar 31, 2024 | -272.51 Mn |
| Dec 31, 2023 | -48,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Jun 30, 2023 | -291.68 Mn |
| Mar 31, 2023 | -132,000.00 |
| Dec 31, 2022 | -219,000.00 |
| Sep 30, 2022 | -369.89 Mn |
| Jun 30, 2022 | -387.50 Mn |
| Mar 31, 2022 | -368.40 Mn |
| Dec 31, 2021 | -347.10 Mn |
| Sep 30, 2021 | -352.80 Mn |
| Jun 30, 2021 | -126,000.00 |